Xin-Gang Cui
Overview
Explore the profile of Xin-Gang Cui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
933
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di S, Chen W, Yang W, Zhang X, Dong K, Tian Y, et al.
Cell Death Dis
. 2024 Jul;
15(7):533.
PMID: 39068164
Renal cell carcinoma (RCC) is considered a "metabolic disease" characterized by elevated glycolysis in patients with advanced RCC. Tyrosine kinase inhibitor (TKI) therapy is currently an important treatment option for...
2.
Wang Y, Chen W, Zhou W, Dong K, Zuo L, Xu D, et al.
J Immunother Cancer
. 2024 Jun;
12(6).
PMID: 38908856
Background: Tertiary lymphoid structures (TLSs) serve as organized lymphoid aggregates that influence immune responses within the tumor microenvironment. This study aims to investigate the characteristics and clinical significance of TLSs...
3.
Chen W, Pan X, Song X, Liu Z, Xu D, Chen J, et al.
Cancer Lett
. 2024 May;
593:216963.
PMID: 38768682
Neoadjuvant tyrosine kinase inhibitor (TKI) therapy is an important treatment option for advanced renal cell carcinoma (RCC). Many RCC patients may fail to respond or be resistant to TKI therapy....
4.
Pan X, Chen W, Xu D, Guan W, Li L, Chen J, et al.
iScience
. 2023 Nov;
26(12):108370.
PMID: 38034348
Previous bulk RNA sequencing or whole genome sequencing on clear cell renal cell carcinoma (ccRCC) subtyping mainly focused on ccRCC cell origin or the complex tumor microenvironment (TME). Based on...
5.
Hu Z, Yu X, Ding R, Liu B, Gu C, Pan X, et al.
J Clin Invest
. 2023 Feb;
133(7).
PMID: 36821379
Activation of STING signaling in DCs promotes antitumor immunity. Aerobic glycolysis is a metabolic hallmark of activated DCs, but how the glycolytic pathway intersects with STING signaling in tumor-infiltrating DCs...
6.
Chen W, Dong K, Pan X, Gan S, Xu D, Chen J, et al.
Cell Death Dis
. 2023 Jan;
14(1):30.
PMID: 36646679
Tumor growth, metastasis and therapeutic response are believed to be regulated by the tumor and its microenvironment (TME) in advanced renal cell carcinoma (RCC). However, the mechanisms underlying genomic, transcriptomic...
7.
Chen W, Yang W, Gong M, He Y, Xu D, Chen J, et al.
Oncol Rep
. 2022 Dec;
49(2).
PMID: 36562383
Clear cell renal cell carcinoma (ccRCC) is a frequent malignant tumor of the kidney which has a dismal prognosis. At present, targeted therapies and immunotherapy have achieved significant results; however,...
8.
Shao Y, Wang X, Sun L, Cui X
World J Clin Cases
. 2022 Nov;
10(31):11536-11541.
PMID: 36387816
Background: As an extramedullary form of proliferating myeloblasts, granulocytic sarcoma (GS) is common in patients with acute myeloid leukemia. GS in the central nervous system is rare, and an intraspinal...
9.
Zhang X, Xu J, Lv J, Pan X, Cao J, Chu J, et al.
World J Clin Cases
. 2022 Aug;
10(17):5646-5654.
PMID: 35979100
Background: Laparoscopic partial nephrectomy has been widely used in renal cell carcinoma treatment. The efficacy of GreenLight laser on Laparoscopic partial nephrectomy is still unknown. Aim: To present the first...
10.
Ding J, Cui X, Chen H, Sun Y, Yu W, Luo J, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406411
Vasculogenic mimicry (VM) has been reported as an alternative channel to increase tumor nutrient supplies and accelerate tumor progression, and is associated with poor survival prognosis in multiple cancers, including...